Unlock instant, AI-driven research and patent intelligence for your innovation.

Benzopyridine azepines and their application as antitumor drugs

A technology of benzopyridine azepine and benzopyridine, which is applied in the direction of antineoplastic drugs, drug combinations, medical preparations containing active ingredients, etc.

Inactive Publication Date: 2015-07-29
SHANGHAI INST OF PHARMA IND CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In view of the complex pathogenesis of tumors, single inhibition of a certain signal transduction pathway can easily make tumors develop drug resistance through evasion mechanisms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzopyridine azepines and their application as antitumor drugs
  • Benzopyridine azepines and their application as antitumor drugs
  • Benzopyridine azepines and their application as antitumor drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0119] Synthesis of 1-[(4-fluorophenyl)amido]cyclopropanecarboxylic acid (Intermediate 2)

[0120] 1.3-Cyclopropanedicarboxylic acid (13.01g, 0.10mol) was dissolved in THF 120mL, under nitrogen protection, triethylamine (10.12g, 0.10mol) was slowly added dropwise at 0°C, and stirred for 15min. Slowly add SOCl2 (9.95 g, 0.10 mol) dropwise to the above system, maintain this temperature, and continue stirring for 30 min. Finally, 60 mL of a THF solution dissolved in 4-fluoroaniline (12.22 g, 0.11 mol) was added dropwise to the reaction liquid, and the reaction was completed under ice bath conditions. After the reaction, the reaction solution was adjusted to pH 9.0 with 10% sodium hydroxide solution, and after stirring for 10 min, the pH of the system was adjusted to 5.0 with 1N HCl, and a solid precipitated out, which was filtered after stirring for 15 min. The filter cake was washed with water until neutral, and dried in vacuum to obtain 14.71 g of a white solid with a yield of...

Embodiment 2

[0124] Synthesis of N-(4-fluorophenyl)-N-(4-hydroxyphenyl)cyclopropane-1,1-diamide (intermediate 3-1)

[0125]4-aminophenol (0.59g, 5.38mmol) and intermediate 2 (1g, 4.48mmol) were dissolved in DMF 15mL, EDC.HCl (1.03g, 5.38mmol) was added thereto, and the reaction was stirred at room temperature for 3h. After the reaction, add water to the reaction solution to precipitate a white solid, add 1N HCl to adjust the pH to 4.0~5.0, stir for 15 minutes, filter, wash the filter cake with water until neutral, and vacuum dry to obtain 1.23 g of white solid, yield 87.9% .

[0126] ESI-MS[M+H] + : m / z 315.4

[0127] 1 H NMR (400MHz, DMSO-d 6 )δppm: 10.17(s,1H,CONH),9.73(s,1H,CONH),9.23(s,1H,OH),6.68~7.83(m,8H,Ar-H),1.48(s,4H,CH 2 CH 2 ).

Embodiment 3

[0129] N 2 -Benzyl-4-chloro-N 2 -Synthesis of phenylpyridine-2,3-diamine (intermediate 5-1)

[0130] Dissolve 2,4-dichloropyridin-3-amine (1.63g, 10mmol) and N-benzylaniline (2.38g, 13mmol) in 30mL of ethanol: water (V / V, 1:6), and add Concentrated hydrochloric acid 0.5mL, heated to 100 ° C, reflux reaction for 8h. After the reaction, cool to room temperature, a white solid precipitates, filter with suction, wash the filter cake with water, add saturated NaHCO 3 : EtOAc (V / V, 1:1) mixed solution 140mL. After stirring for 30 minutes, the layers were separated, and the organic layer was washed with saturated sodium chloride solution, dried, filtered, and concentrated to obtain 1.78 g of off-white solid with a yield of 57.4%. The product does not need to be purified and can be directly used for the next reaction.

[0131] ESI-MS[M+H] + : m / z 310.4

[0132] 1 H NMR (400MHz, DMSO-d 6 )δppm: 8.02(d,1H,J=8Hz,pyridine-5-H),6.85~7.79(m,11H,Ar-H),5.25(s,2H,NH 2 ),4.51(s,2H,CH ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided are a benazepine compound, a composition containing the compound and a use of the compound in the preparation of anti-tumor drugs. The benazepine compound is a compound shown in formula (I) or a pharmaceutically acceptable salt thereof, which has a stronger anti-tumor activity and selectivity, and a lower toxic side effect.

Description

technical field [0001] The invention relates to a benzopyridine azepine compound, a preparation method thereof and an application of the compound in preventing and treating related diseases such as tumors by blocking the HGF / c-Met signal pathway. Background technique [0002] Local invasion and metastasis of primary tumors to other tissues is one of the most important factors affecting the survival of cancer patients. The death of most cancer patients is caused by tumor metastasis, and this process greatly depends on the motility of tumor cells and cell proliferation. [0003] Hepatocyte growth factor (HGF), also known as discrete factor (Scatter Factor, SF), is a multifunctional cytokine that can promote the growth of various types of cells such as liver cells, epithelial cells, endothelial cells, and hematopoietic cells. growth, migration and morphogenesis. The c-Met transmembrane protein is a protein product encoded by the c-met proto-oncogene and is a high-affinity rec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04C07D498/04C07D513/04A61K31/554A61K31/553A61K31/5513A61P35/00
CPCC07D513/04C07D471/04C07D498/04A61P35/00
Inventor 李建其王文雅周斌解鹏杜振新卢秀莲翁志洁张庆伟黄道伟
Owner SHANGHAI INST OF PHARMA IND CO LTD